MED TALK: AN INTEGRATIVE APPROACH TO STEM CELL THERAPY:

ABOUT THE LECTURE:
Stem cells have the potential to become any cell in the body and the explosion of clinical and experimental data has overwhelmed practitioners. The goal of this lecture is to provide a framework on how to assess the growing literature on stem cell therapy, so practitioners can gain the knowledge to educate their patients to navigate this growing and complex new area of medicine. 

Learning Objectives:
a) What stem cells are? The various definitions and sources
b) The up to date literature on safety and efficacy
c) The preclinical data on efficacy for various conditions such as cardiac and neurological indications
d) The role of exosomes and very small stem cells (VSEL’s) in the future of stem cell therapy


Ahvie Herskowitz, MD

ABOUT DR. HERSKOWITZ:
Dr. Herskowitz’s extensive training includes a medical degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center. During his 12 years at Johns Hopkins, where he became Associate Professor of Medicine and Immunology and Molecular Microbiology. His clinical responsibilities were complemented by directing a multidisciplinary research team in the study of molecular and immunological mechanisms of inflammation, autoimmunity, heart attack, heart transplantation and heart failure.

Over the past 15 years, he helped establish and lead innovative health care non-profit research and development organizations that have domestic and worldwide social impact. He served as Head of Research at the Ischemia Research and Education Foundation, working with over 100 leading heart surgery hospitals around the world, dedicated to reducing adverse outcomes during and after heart surgery. Since 1999, Clinical Professor of Medicine at University of California at San Francisco, and Co-founder and Chief Medical Officer of the Institute for OneWorld Health, the first non-profit pharmaceutical company in the United States. He is Chairman of the Board of Directors for iRND3, (www.irnd3.org) an organization that discovers new medicines for rare and neglected diseases. He is also on the Board for PVRI, Pulmonary Vascular Research Institute, and is Vice President of the ACAM (American College for Advancement in Medicine), the oldest Integrative Medicine organization in the U.S.

 
 

NEED ASSISTANCE REGISTERING? A Meeting by Design
1.888.995.3088  |  info@ameetingbydesign.com

ACAM HEADQUARTERS: 
1.800.532.3688  |  info@acam.org  |  www.acam.org